Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could an iPhone app help beat eating disorders?

NCT ID NCT06226233

Ongoing Symptom relief Sponsor: King's College London Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a digital self-help app called Juniver can reduce symptoms of eating disorders like anorexia, bulimia, and binge eating. 300 adults in the UK and US will use the app for 12 weeks and report their symptoms. The app includes therapy-based lessons, interactive tools, and peer support groups.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Juniver program (digital self-help app)
What this could lead to
If it works, this could provide a widely accessible, low-cost digital tool to help people manage eating disorder symptoms from home.
What could go wrong
This is an early-stage trial with no blinding or placebo control, and results rely on self-reported symptoms. The app may not work for severe cases or those without an iPhone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANOREXIA NERVOSA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anorexia nervosa avoidant/restrictive food intake disorder binge eating disorder Binge-Eating Disorder bulimia nervosa eating disorder Feeding and Eating Disorders Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANOREXIA NERVOSA BINGE EATING BINGE EATING DISORDER BULIMIA NERVOSA DISORDERED EATING EATING DISORDERS FEEDING AND EATING DISORDERS

Contacts and locations

Locations

  • King's College London

    London, London, SE5 8AZ, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.